NASDAQ: VKTX · Biotechnology
Over the past week, Viking Therapeutics (VKTX) drew about 135 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 82% bullish but is at odds: Reddit runs 100% bullish while X sits at just 47%. Wall Street is more constructive, with 18 of 20 analysts rating VKTX a buy.
There is little buzz around VKTX this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 90% buy share sits next to a crowd that ranges from X at 47% to Reddit at 100%. No other tracker puts the two side by side.
20 analysts have weighed in: a Strong Buy consensus: 18 buy calls against 0 sell, with an average 12-month price target of $92.39.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 8 points above the crowd average of 82%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while X sits at 47%, a 53-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Viking Therapeutics (VKTX) buzz held elevated around 67.3 while the price drifted up 4.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.7M shares. Over the last 7 trading days, VKTX gained 3.0%. Buzz activity in the recent week averaged 45.9 and was highly volatile, swinging between 21.1 and 72.0. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 15 of the 22 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for VKTX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live VKTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (18 / 2 / 0) |
| Crowd bullish (7d) | 82% |
| Avg price target | $92.39 |
| Most bullish source | Reddit, 100% |
| Most bearish source | X, 47% |
| Sentiment spread | 53 pts |
| Mentions (7d) | 135 |
| Market cap | $3.96B |
| EPS · Beta | -$4.67 · 0.7 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Viking Therapeutics (VKTX) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 82% bullish across 3 active sources. Those sources contribute 135 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Viking Therapeutics (VKTX) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Viking Therapeutics (VKTX), averaging 82% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and X at 47%, a 53-point spread. On the professional side, 18 of 20 analysts rate VKTX a buy.
Of the 20 analysts covering Viking Therapeutics (VKTX), 18 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $92.39. That puts the street ahead of the crowd, which averages 82% bullish.
Viking Therapeutics (VKTX)'s cross-source average is bullish at 82% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. Reddit reads 100% bullish, News reads 100% bullish and x coverage is the most negative at 47% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Viking Therapeutics (VKTX) at 82% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is x at 47% bullish. 3-day activity momentum is falling across X and News. The buy signal carries 93/100 conviction.
X is the dominant discussion channel with 128 mentions (95% of total volume). News contributes 6 mentions and Reddit contributes 1 mention. The cross-source average is bullish at 82% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. VKTX's buy signal at 93/100 conviction reflects a bullish cross-source average at 82% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The VKTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key